T. Rowe Price Associates’s Hanesbrands HBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-300,372
Closed -$1.98M 3102
2025
Q3
$1.98M Buy
300,372
+16,814
+6% +$92.9K ﹤0.01% 1736
2025
Q2
$1.3M Buy
283,558
+35,175
+14% +$170K ﹤0.01% 1852
2025
Q1
$1.43M Buy
248,383
+17,745
+8% +$124K ﹤0.01% 1766
2024
Q4
$1.88M Buy
230,638
+39,789
+21% +$313K ﹤0.01% 1685
2024
Q3
$1.4M Buy
190,849
+6,656
+4% +$39.8K ﹤0.01% 1810
2024
Q2
$909K Buy
184,193
+21,046
+13% +$103K ﹤0.01% 1939
2024
Q1
$947K Buy
163,147
+12,637
+8% +$60.6K ﹤0.01% 1937
2023
Q4
$672K Sell
150,510
-33,060
-18% -$135K ﹤0.01% 2048
2023
Q3
$727K Buy
183,570
+17,865
+11% +$86.5K ﹤0.01% 1943
2023
Q2
$753K Buy
165,705
+25,237
+18% +$115K ﹤0.01% 1945
2023
Q1
$739K Buy
140,468
+8,758
+7% +$55.1K ﹤0.01% 1926
2022
Q4
$838K Buy
131,710
+4,138
+3% +$28.4K ﹤0.01% 1862
2022
Q3
$888K Buy
127,572
+3,339
+3% +$32.8K ﹤0.01% 1813
2022
Q2
$1.28M Buy
124,233
+7,161
+6% +$89K ﹤0.01% 1785
2022
Q1
$1.74M Buy
117,072
+28,059
+32% +$441K ﹤0.01% 1741
2021
Q4
$1.49M Sell
89,013
-1,166,925
-93% -$19.8M ﹤0.01% 1829
2021
Q3
$21.6M Sell
1,255,938
-2,972,640
-70% -$55.7M ﹤0.01% 1276
2021
Q2
$78.9M Sell
4,228,578
-1,748,272
-29% -$34.6M 0.01% 872
2021
Q1
$118M Sell
5,976,850
-129,566
-2% -$2.29M 0.01% 722
2020
Q4
$89M Buy
6,106,416
+1,890,661
+45% +$28.5M 0.01% 764
2020
Q3
$66.4M Buy
4,215,755
+1,311,747
+45% +$19.3M 0.01% 780
2020
Q2
$32.8M Buy
2,904,008
+297,151
+11% +$2.97M ﹤0.01% 985
2020
Q1
$20.5M Buy
2,606,857
+1,966,730
+307% +$24.9M ﹤0.01% 1071
2019
Q4
$9.51M Buy
640,127
+15,906
+3% +$242K ﹤0.01% 1318
2019
Q3
$9.56M Sell
624,221
-30,639
-5% -$466K ﹤0.01% 1298
2019
Q2
$11.3M Hold
654,860
﹤0.01% 1294
2019
Q1
$11.7M Buy
654,860
+103,000
+19% +$1.71M ﹤0.01% 1295
2018
Q4
$6.92M Hold
551,860
﹤0.01% 1369
2018
Q3
$10.2M Sell
551,860
-13,215,800
-96% -$256M ﹤0.01% 1369
2018
Q2
$303M Buy
13,767,660
+13,137,900
+2,086% +$248M 0.05% 373
2018
Q1
$11.6M Sell
629,760
-101,600
-14% -$2.1M ﹤0.01% 1307
2017
Q4
$15.3M Sell
731,360
-145,436
-17% -$3.11M ﹤0.01% 1262
2017
Q3
$21.6M Sell
876,796
-68,760
-7% -$1.65M ﹤0.01% 1153
2017
Q2
$21.9M Sell
945,556
-397,844
-30% -$8.58M ﹤0.01% 1143
2017
Q1
$27.9M Sell
1,343,400
-11,638,909
-90% -$247M 0.01% 1025
2016
Q4
$280M Sell
12,982,309
-44,513,102
-77% -$1.06B 0.06% 345
2016
Q3
$1.45B Sell
57,495,411
-5,135,106
-8% -$135M 0.29% 80
2016
Q2
$1.57B Buy
62,630,517
+1,221,642
+2% +$33.3M 0.33% 63
2016
Q1
$1.74B Sell
61,408,875
-5,312,348
-8% -$152M 0.37% 57
2015
Q4
$1.96B Buy
66,721,223
+5,013,151
+8% +$150M 0.41% 51
2015
Q3
$1.79B Buy
61,708,072
+8,201,586
+15% +$254M 0.4% 54
2015
Q2
$1.78B Buy
53,506,486
+1,699,715
+3% +$55.6M 0.37% 62
2015
Q1
$1.74B Buy
51,806,771
+3,242,255
+7% +$98.3M 0.36% 64
2014
Q4
$1.36B Buy
48,564,516
+11,197,728
+30% +$307M 0.29% 91
2014
Q3
$1B Buy
37,366,788
+5,796,708
+18% +$147M 0.22% 116
2014
Q2
$777M Buy
31,570,080
+23,298,292
+282% +$481M 0.17% 154
2014
Q1
$158M Buy
8,271,788
+6,687,988
+422% +$120M 0.04% 493
2013
Q4
$27.8M Buy
1,583,800
+343,000
+28% +$5.71M 0.01% 1001
2013
Q3
$19.3M Buy
1,240,800
+208,000
+20% +$3.09M ﹤0.01% 1086
2013
Q2
$13.3M Buy
+1,032,800
New +$12.7M ﹤0.01% 1180

Other funds holding HBI

T. Rowe Price Associates's HBI Position: Q4 2025 in Review

T. Rowe Price Associates sold out of Hanesbrands (HBI) in Q4 2025, closing a stake of 300,372 shares — an estimated $1.98M sold.

T. Rowe Price Associates first reported a position in HBI in Q2 2013 and held it in 50 quarters. The position peaked at $1.96B in Q4 2015. 2 funds tracked by Wall St. Rank hold HBI as of Q4 2025.

  • T. Rowe Price Associates reported no remaining Hanesbrands position as of Q4 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 300,372 Hanesbrands shares in Q4 2025, an estimated $1.98M.
  • T. Rowe Price Associates first reported a position in Hanesbrands in Q2 2013 and held it in 50 quarters.
  • T. Rowe Price Associates's Hanesbrands position peaked at $1.96B in Q4 2015.
  • 2 funds tracked by Wall St. Rank held Hanesbrands as of Q4 2025.

Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.